Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com

Rhea-AI Summary

Bionoid Pharma (OTC Pink: BINP) announced its intent to acquire AiMaverickIntel.com, a leading Audience Acquisition platform utilizing Artificial Intelligence (AI). This move follows the cancellation of a previous agreement to acquire Global Alerts Corp. BINP's CEO, Wayne Cockburn, highlighted this acquisition as a pivotal step in BINP's growth, aimed at boosting audience targeting and customer acquisition capabilities. The strategic shift from Global Alerts Corp. to AiMaverickIntel.com underscores BINP’s commitment to leveraging advanced technology for enhanced engagement strategies.

Positive

• Strategic acquisition of AiMaverickIntel.com enhances audience targeting and acquisition capabilities.
• Positions BINP at the forefront of innovation in the industry.

Negative

• Cancellation of the previously announced Global Alerts Corp acquisition.

TORONTO, ON / ACCESSWIRE / June 18, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC Pink:BINP) today announced that it has entered into a Letter of Intent to acquire AiMaverickIntel.com, a leading Audience Acquisition platform powered by Artificial Intelligence (AI). This strategic acquisition underscores BINP's interest in leveraging advanced technology to enhance audience engagement and acquisition strategies.

This new agreement follows the cancellation of a previously announced agreement to acquire Global Alerts Corp. As detailed in a prior release, Bionoid Pharma signed a binding letter of intent to acquire Global Alerts Corp., however strategic considerations led the company to pursue the acquisition of AiMaverickIntel.com instead.

Wayne Cockburn, CEO of BINP, commented, "We are excited with the opportunity to acquire AiMaverickIntel.com, which marks a significant milestone in our growth strategy. Their platform will empower us to enhance audience targeting and customer acquisition efforts, positioning BINP at the forefront of innovation in the industry."

About AiMaverickIntel.com

AiMaverickIntel.com represents the future of audience engagement. Utilizing state-of-the-art AI technology, the platform revolutionizes how companies identify, reach, and engage their target audience segments. Its advanced algorithms and machine learning capabilities provide actionable insights and optimize customer acquisition processes, resulting in unparalleled efficiency and effectiveness in marketing campaigns. By integrating AiMaverickIntel.com's capabilities, BINP aims to achieve substantial improvements in customer engagement and acquisition metrics, driving sustainable growth and competitive advantage.

The transaction is expected to close in within 45 days, pending customary closing conditions and regulatory approvals.

For further information, contact:

Wayne Cockburn, CEO
Phone: (905) 505-0770

SOURCE: Bionoid Pharma, Inc.

View the original press release on accesswire.com

FAQ

What recent acquisition has Bionoid Pharma (BINP) announced?

Bionoid Pharma has announced its intent to acquire AiMaverickIntel.com, an AI-powered Audience Acquisition platform.

Why did Bionoid Pharma cancel its agreement to acquire Global Alerts Corp?

Strategic considerations led Bionoid Pharma to pursue the acquisition of AiMaverickIntel.com instead of Global Alerts Corp.

How does BINP's acquisition of AiMaverickIntel.com benefit the company?

The acquisition is aimed at enhancing BINP's audience targeting and customer acquisition efforts, positioning it at the forefront of industry innovation.

When did Bionoid Pharma announce its intent to acquire AiMaverickIntel.com?

Bionoid Pharma announced its intent to acquire AiMaverickIntel.com on June 18, 2024.